If you wish to receive all of the company’s financial communications in real time, you can register directly by email at the following address: [email protected]
Lyon (France), and Cambridge, MA (US) May 17, 2022 – ERYTECH Pharma (Euronext & Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drugs in red blood cells (RBCs), announces today that its Managing Director, Gil Beyen, will make a presentation at the HC Wainwright Global Investment Conference. The conference will be held in a hybrid format from May 23-26, 2022 in Miami, USA.